Conivaptan hydrochloride
Conivaptan hydrochloride is a dual V1A/V2 vasopressin receptor antagonist used to treat euvolemic and hypervolemic hyponatremia. It is a valuable research tool for studying vasopressin signaling pathways in both in vitro binding assays and in vivo models of fluid and electrolyte disorders.
Product Specifications
CAS Number
168626-94-6
Product Name Alternative
Conivaptan, Conivaptan HCl, Conivaptan Hydrochloride, Conivaptan hydrochloride, inhibit, Inhibitor, YM087, YM-087, YM 087, VasopressinReceptor, Vasopressin Receptor, vasopressin receptor 1a, vasopressin receptor 2, Vaprisol
Field of Research
Pharmacology & Drug Discovery
Purity
98.33% (May vary between batches)
Solubility
DMSO:99 mg/mL (185.03 mM) ; Ethanol:7 mg/mL (13.08 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (6.17 mM)
Smiles
Cl.Cc1nc-2c (CCN (C (=O) c3ccc (NC (=O) c4ccccc4-c4ccccc4) cc3) c3ccccc-23) [nH]1
Molecular Formula
C32H26N4O2·HCl
Molecular Weight
535.04
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
041523-AP 200 µL
SECISBP2, ID (SECISBP2, SBP2, Selenocysteine insertion sequence-binding protein 2) (AP) discontinued
Sign In for Pricing
View Details TRV-0028682 96 Tests
Multiplex Assay Kit for p53 Upregulated Modulator Of Apoptosis (PUMA), etc. by FLIA (Flow Luminescence Immunoassay)
Sign In for Pricing
View Details 